To seek to achieve long-term capital growth.
Name | % Net Assets |
---|---|
Wilmington | 4.3% |
Concurrent Technologies | 3.7% |
Renishaw | 3.3% |
Vebnet | 3.2% |
System C Healthcare | 3.2% |
NCipher | 3.1% |
Genetix | 3.0% |
Mama | 3.0% |
RWS Holdings | 3.0% |
Brooks Macdonald | 2.9% |
Key | % Net Assets |
---|---|
Wilmington | 4.3% |
Concurrent Technologies | 3.7% |
Renishaw | 3.3% |
Vebnet | 3.2% |
Other | 85.5% |
Date | 21-Nov-2024 |
---|---|
Bid | 1,738.07p |
Offer | 1,774.16p |
Currency | GBP |
Change | -6.19p |
% | -0.35% |
YTD change | -41.06p |
YTD % | -2.28% |
Fund Inception | 07/08/1995 |
---|---|
Fund Manager | Anthony Cross / Julian Fosh |
TER | 1.66 (31-Oct-2013) |
Minimum Investment | |
---|---|
Initial | £2500 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.15 |
You are here: research